{"id":"W2973068166","doi":"10.1161/circulationaha.119.040167","title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; 123 Certification (Canada)","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Vascular; St. Jude Medical; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Sanofi; Abiomed; Osprey Medical; Chiesi USA; Claret Medical; Biosense Webster; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Cook Medical; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Abbott Laboratories; CSL Behring; University of Florida; B. Braun Melsungen; Amgen; Pfizer; Medicure","keywords":"Medicine; Percutaneous coronary intervention; Clinical trial; Population; Guideline; Regulatory affairs; Intensive care medicine; Medical emergency; Myocardial infarction; Internal medicine; Environmental health; Pathology; Public administration","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004537357,0.001077665,0.003651411,0.004111956,0.0002589485,0.001479204,0.001065498,0.001462331,0.001450532],"category_scores_gemma":[0.008159135,0.0003760205,0.002174363,0.003349091,0.000625083,0.001411632,0.0009101207,0.001992867,0.000280114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009517437,"about_ca_system_score_gemma":0.002492737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002548774,"about_ca_topic_score_gemma":0.004528535,"domain_scores_codex":[0.9959186,0.002047913,0.001053275,0.0002346667,0.0006580927,0.00008746572],"domain_scores_gemma":[0.9960575,0.002663131,0.0007956635,0.00005129347,0.0003764807,0.00005592642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005108209,0.00006681675,0.001927953,0.2355795,0.002997539,0.0001212969,0.0002442003,0.0003025155,0.0004129407,0.003992974,0.01349065,0.7403528],"study_design_scores_gemma":[0.001180733,0.0008032132,0.02354611,0.4754592,0.02136287,0.002781763,0.0008484843,0.0007200653,0.00101166,0.01073007,0.4613774,0.0001783779],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002282996,0.9988552,0.0001175364,0.0003949011,0.00009179621,0.00003604651,0.00002618281,0.000001587192,0.0002483128],"genre_scores_gemma":[0.00370129,0.9949446,0.000475777,0.0005325016,0.0001344911,0.00006665607,0.0000650173,0.000001114384,0.00007848292],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004537357,"threshold_uncertainty_score":0.02399611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02278705769970059,"score_gpt":0.2842924585683699,"score_spread":0.2615054008686693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}